Atlanta Clinical and Translational Science Institute (TL1)

响应国家努力发展、改善和 提供临床和翻译科学，埃默里大学的领导层挑战了教职员工和 管理部门，以改变大学内部的临床和翻译研究及其众多 组件和附属公司。与医疗保健、教育和跨学科领域的持续合作 在研究方面，埃默里还选择了在亚特兰大都会聘请它的两个亲密学术合作伙伴- 莫尔豪斯医学院(MSM)和佐治亚理工学院(GA Tech)成立 亚特兰大临床与转化科学研究所(亚特兰大-CTSI)。这一战略性的多机构 联盟提供了令人信服和独特的优势。埃默里是美国领先的医疗保健公司之一 学术研究机构，在NIH资助的研究中全国排名第19；GA Tech是全国 生物医学工程和创新系统工程在医疗保健中的应用领先者 MSM是一所历史悠久的黑人医学院，被公认为全国扩张的领先者 生物医学研究的种族多样性，致力于社区参与努力消除 健康差距，并作为培训少数群体调查人员的渠道。已建立的 合作伙伴关系和多样化的教职员工使亚特兰大-CTSI能够将强大的临床、翻译、 埃默里的培训和基本发现计划与健康差距、培训和社区 MSM的推广重点与GA Tech的工程和生物信息学成就。 规划工作还导致创建了一个新的、创新的儿科临床和翻译 研究计划和与亚特兰大儿童保健中心的合作伙伴关系，与 佐治亚州新兴生物技术社区与Kaiser Permanente，以及进一步发展 与国家赞助机构(佐治亚州研究联盟)和 退伍军人事务部。亚特兰大-CTSI是一种旨在利用科学、技术和 这些机构围绕发现、培训和社区的主要目标的临床优势 参与创建一个新的全市范围的临床和转化研究之家。其他新计划 协同伙伴关系产生的结果包括一个创新的试点项目计划Pico-TraCS， 综合临床互动和生物医学信息学网络(CIN和BIN)，创建 生物信息学的飞跃--技术“管道”与翻译方法开发学院 倡议，人类研究促进办公室，创造性的K30/K12和T32方案，以及 杰出的社区参与计划。对亚特兰大-CTSI的机构支持是 不同凡响。亚特兰大-CTSI利用了Emory、MSM和GA技术的互补优势，并 其他GA机构，以促进临床和翻译科学的学科，并改善 我们社区的医疗保健。

In response to the national effort to develop, improve, and deliver clinical and translational science, the leadership of Emory University challenged both faculty and the administration to transform clinical and translational research within the University and its numerous components and affiliates. With ongoing collaborations in heath-care, education, and interdisciplinary research, Emory also chose to engage two of its close academic partners in metropolitan Atlanta - Morehouse School of Medicine (MSM) and Georgia Institute of Technology (GA Tech) to form the Atlanta Clinical and Translational Science Institute (Atlanta-CTSI). This strategic multi-institutional alliance offered compelling and unique advantages. Emory is one of the nation's leading healthcare and academic research institutions, ranking 19th nationally in NIH funded research; GA Tech is a national leader in biomedical engineering and the application of innovative systems engineering to health care solutions; and MSM is a historically black medical school recognized as a national leader in expanding the ethnic diversity of biomedical research, dedicated to community engagement in efforts to eliminate health disparities and serving as a pipeline for training minority investigators. The established partnerships and diverse faculty enable the Atlanta-CTSI to combine strong clinical, translational, training and basic discovery programs at Emory with the health disparities, training and community outreach focus of MSM together with the engineering and bioinformatics achievements of GA Tech. The planning efforts also led to the creation of a new and innovative pediatric clinical and translational research program and a partnership with Children's Healthcare of Atlanta, new partnerships with the emerging Georgia biotechnology community and with Kaiser Permanente, and the further development of partnerships with state sponsored agencies (Georgia Research Alliance) and with the Department of Veterans Affairs. The Atlanta-CTSI is a model designed to harness the scientific, technological, and clinical advantages of these institutions around the major aims of discovery, training, and community engagement to create a new city wide home for clinical and translational research. Other new programs resulting from the synergistic partnership include an innovative pilot projects program PiCo-TraCS, integrated clinical interactions and biomedical informatics networks (CIN and BIN), creation of a technology "pipeline" and Academy for Translational Methods Development, a bioinformatics Leapfrog initiative, a facilitating Office of Human Studies Research, creative K30/K12 and T32 programs, and an outstanding community engagement program. The institutional support for the Atlanta-CTSI is exceptional. The Atlanta-CTSI utilizes the complementary strengths of Emory, MSM, and GA Tech and other GA institutions to promote the discipline of clinical and translational science and to improve the healthcare of our community.